menu search

Arvinas to Participate in Upcoming Investor Conferences

Arvinas to Participate in Upcoming Investor Conferences
NEW HAVEN, Conn., Feb. 06, 2023 (GLOBE NEWSWIRE) — Arvinas, Inc. (Nasdaq: ARVN), a clinical-stage biotechnology company creating a new class of drugs based on targeted protein degradation, today announced that management will participate in three upcoming investor conferences: Guggenheim Oncology Conference on Thursday, February 9. Ron Peck, M.D., Chief Medical Officer, and Sean Cassidy, […] The post Arvinas to Participate in Upcoming Investor Conferences appeared first on ForexTV... Read More
Posted: Feb 6 2023, 21:30
Author Name: forextv
Views: 110997

Search within

Pages Search Results: